VIVET THERAPEUTICS ATTENDING 2018 ESGCT 26TH ANNUAL CONGRESS IN LAUSANNE
Vivet Therapeutics will be at the upcoming European Society of Gene And Cell Therapy (ESGCT) 26th annual congress in Lausanne…
Vivet Presenting at 2018 Chardan Gene Therapy conference in New York
Vivet Therapeutics CEO, Jean-Philippe Combal, will be presenting and hosting 1×1 meetings during Chardan Gene Therapy conference in New York on October…
Vivet attending FierceBiotech 3rd Drug Development Forum in Boston
Vivet Therapeutics’ CEO, Jean-Philippe Combal
VIVET ANNOUNCES PRESENTATIONS ON ITS LEAD PRODUCT VTX-801 AT THE 2018 COPPER MEETING
Vivet Therapeutics announces different presentations
VIVET ATTENDING WEDBUSH PACGROW 2018 HEALTHCARE CONFERENCE IN NEW YORK
Vivet Therapeutics’ CEO, Jean-Philippe Combal
Vivet attending BIO 2018 in Boston on June 4-7
Vivet’s CEO, Jean-Philippe Combal and Thomas Daniel, BD Director, will be hosting 1×1 meetings during BIO 2018 in Boston on June 4-7.
VIVET ANNOUNCES 2 PRESENTATIONS ON ITS LEAD PRODUCT VTX-801 AT THE 2018 ASGCT ANNUAL MEETING
Vivet Therapeutics announces 2 presentations on its lead product
Vivet sponsoring and attending Wilson Disease Association (WDA) 2018 Annual Conference
Vivet Therapeutics’ CEO, Jean-Philippe Combal
Vivet announces presentation on its lead product at the upcoming 2018 International Liver Congress
Vivet Therapeutics announces presentation on its lead product at the upcoming
Vivet is sponsoring and attending the 9th Congress of the Spanish Society for Gene and Cell Therapy
Vivet is a gold sponsor of the
